1 Min Read
Feb 7 (Reuters) - Merrimack Pharmaceuticals Inc
* Merrimack Pharmaceuticals - on Feb 6, co terminated consulting and confidentiality agreement between co, ROBERT MULROY, former president, CEO Source text: (bit.ly/2lkXi8c) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.